While FBG is essential for assessing insulin resistance and hs-CRP is useful for measuring systemic inflammation, neither captures the intricate relationship between lipid metabolism and atherosclerotic risk as well as AIP. The gene discussed is MAP3K14; the disease is autoimmune pancreatitis.